U.S. Department of Health and Human Services Secretary Kathleen Sebelius has announced that nearly $50 million will be invested in public health workforce development.

The American Society of Radiologic Technologists (ASRT) Education and Research Foundation and Elekta have named the recipients of the 2012 Elekta Radiation Therapy Scholarship.

Patients who have had large vessel occlusion strokes but are ineligible for (or refractory to) intravenous recombinant tissue plasminogen activator should be treated with the Trevo Retriever instead of the Merci Retriever, according to the TREVO 2 investigators, who presented trial results Aug. 26 at the European Society of Cardiology Congress in Munich.

The latest edition of American College of Cardiology's (ACC) CardioSurve newsletter takes a look at the impact and utilization of information from the clinical perspective at the point of care, where digital access is as common as a stethoscope, to the back office procedures once mired in paper processing that now operate on an information cloud. This focus on data streaming is an important facet of the continuum of care that impacts all aspects of practices from patient outcomes to reimbursement.

A quartet of life science trade associations encouraged the Centers for Medicare & Medicaid Services to publish a final rule implementing the Physician Payments Sunshine Act, a provision of the Patient Protection and Affordable Care Act that would require pharmaceutical, medical device, biological and medical supply manufacturers to report payments made to providers and teaching hospitals to the Department of Health and Human Services.

The Congressional Budget Office (CBO) has lowered its healthcare spending estimates for 2013 to 2022. An Aug. 22 report projects Medicaid and Medicare spending will be $494 billion less than a March estimate had predicted.

A timeline delay, new core measures and an electronic reporting mandate are the highlights of the meaningful use Stage 2 final rule, published Aug. 23 by the Centers for Medicare & Medicaid Services.

The National Heart, Lung and Blood Institute, a part of the National Institutes of Health, is launching the Cardiovascular Inflammation Reduction Trial, an international multicenter trial designed to determine whether a common anti-inflammatory drug can reduce heart attacks, strokes and deaths due to cardiovascular disease in people at high risk for them.